Filippo D. B.
- Country
- Italy
- Department
- Department of Oncology and Hematology
Research Overview
- Evaluation of AMG 193 Combined with Additional Therapies in Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers with Homozygous MTAP-Deletion
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- Evaluation of Anthracycline-Taxane Chemotherapy Combined with Fasting-Mimicking Diet and Metformin in Triple Negative Breast Cancer Patients
Data & Insights
Has run more than one trial at 46 of 235 partner sites.
Specializations
Thoracic Oncology
Specialized in treating various forms of lung cancer, with particular focus on non-small cell lung cancer (NSCLC) including advanced and metastatic cases. Research encompasses novel treatments for tumors with specific genetic alterations including ROS1, EGFR, and KRAS mutations.
- Advanced NSCLC treatments
- Targeted therapies for genetic mutations
- Small-cell lung cancer interventions
Gastrointestinal Oncology
Conducts research in various gastrointestinal malignancies, with particular expertise in cholangiocarcinoma and hepatocellular carcinoma. Investigates novel therapeutic approaches for colorectal cancer and advanced biliary tract cancers.
- Biliary tract cancer treatments
- Liver cancer therapies
- Gastroesophageal cancer interventions
Precision Medicine
Focuses on developing personalized treatment approaches for various advanced solid tumors. Expertise in implementing targeted therapies and investigating novel therapeutic combinations including immunotherapy treatments.
- Biomarker-driven therapies
- Novel drug combinations
- Immunotherapy applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.